Perimeter Medical Imaging AI, Inc. a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, is providing, as required by section 11 of BC Instrument 51-517 - Temporary Exemption from Certain Corporate Finance Requirements a 30-day update on its previously-announced 45-day extension of the filing of its ...

Perimeter Medical Imaging AI, Inc. (TSXV:PINK)(FSE:4PC), a medical technology company driven to transform cancer surgery with ultra-high-resolution, real-time, advanced imaging tools to address areas of high unmet medical need, is providing, as required by section 11(2)(a) of BC Instrument 51-517 - Temporary Exemption from Certain Corporate Finance Requirements ("BCI 51-517"), a 30-day update on its previously-announced 45-day extension of the filing of its interim financial statements for its second quarter ending June 30, 2020

Previously, on August 31, 2020, Perimeter announced that it would be relying on a 45-day extension period until October 15, 2020 under BCI 51-517. The Company continues to work within this extension period to complete the Interim Documents and expects to file the Interim Documents before October 15, 2020. In the interim, members of the Company's management and other insiders will be subject to a trading black-out that reflects the principles in section 9 of National Policy 11-207 until the Financial Statements have been filed.

As background, on May 20, 2020, the Canadian Securities Administrators issued a notice stating that securities regulators will be providing coordinated relief consisting of a 45-day extension for certain periodic filings required to be made during the period from June 2, 2020 to August 31, 2020, as a result of the COVID-19 pandemic. Accordingly, the British Columbia Securities Commission has enacted BCI 51-517. Perimeter is relying on the temporary exemption pursuant to BCI 51-517 with respect to the requirement to file:

i. quarterly financial statements for the period ended June 30, 2020 (the "Financial Statements") within 60 days after the end of the interim period as required by section 4.4(b) of National Instrument 51-102 - Continuous Disclosure Requirements ("NI 51-102");

ii. management discussion and analysis for the periods covered in the Financial Statements (the "MD&A") within 60 days of the interim period as required by section 5.1(2) of NI 51-102; and

iii. certifications of the Financial Statements (collectively with the Financial Statements and MD&A, the "Interim Documents") pursuant to section 5.1 of National Instrument 52-109 - Certification of Disclosure in Issuers' Annual and Interim Filings.

The Company confirms that since the filing of its audited consolidated financial statements for the years ended December 31, 2019 and December 31, 2018, there have been no material business developments other than those disclosed through news releases and filed under the Company's SEDAR profile at www.sedar.com.

About Perimeter Medical Imaging AI, Inc.

Perimeter Medical Imaging AI (TSXV:PINK)(FSE:4PC) is a Toronto-based company with U.S. headquarters in Dallas, Texas that is developing, with plans to commercialize, advanced imaging tools that allow surgeons, radiologists, and pathologists to visualize microscopic tissue structures during a clinical procedure. Perimeter's OTIS™ platform is a point-of-care imaging system that provides clinicians with real-time, ultra-high-resolution, sub-surface image volumes of the margin (1-2 mm below the surface) of an excised tissue specimen.

The ability to visualize microscopic tissue structures during a clinical procedure in addition to standard of care tissue assessment for decision making during the procedure has the potential to result in better long-term outcomes for patients and lower costs to the healthcare system. Perimeter's OTIS™ platform is cleared by FDA as an imaging tool in the evaluation of excised human tissue microstructure by providing two-dimensional, cross-sectional, real-time depth visualization, with image review manipulation software for identifying and annotating regions of interest. In addition, Perimeter is developing advanced artificial intelligence/machine learning image assessment tools intended to increase the efficiency of review.

Perimeter's ticker symbol "PINK" is a reference to the pink ribbons used during Breast Cancer Awareness Month by the Canadian Cancer Society and the American Cancer Society, driving home the company's dedication to helping surgeons, radiologists and pathologists use Perimeter's imaging technology and AI (Artificial Intelligence) in the fight against breast cancer, which is estimated to account for 30% of all female cancer diagnoses this year.

CONTACT:

Jodi Regts
Corporate Communications / Investor Relations
Perimeter Medical Imaging AI, Inc.
+1 778-999-5634
media@perimetermed.com

NEITHER THE TSXV NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSXV) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE. This news release contains statements that may constitute "forward-looking information" within the meaning of applicable Canadian securities legislation. In this news release, words such as "may", "would", "could", "will", "likely", "believe", "expect", "anticipate", "intend", "plan", "estimate" and similar words and the negative form thereof are used to identify forward-looking statements. Forward-looking information may include, among others, statements regarding the expected date of filing the Interim Documents, or the assumptions underlying any of the foregoing. Forward-looking statements should not be read as guarantees of future performance or results, and will not necessarily be accurate indications of whether, or the times at or by which, such future performance will be achieved. No assurance can be given that any events anticipated by the forward-looking information will transpire or occur. Forward-looking information is based on information available at the time and/or management's good-faith belief with respect to future events and are subject to known or unknown risks, uncertainties, assumptions and other unpredictable factors, many of which are beyond Perimeter's control. Such forward-looking statements reflect Perimeter's current view with respect to future events, but are inherently subject to significant medical, scientific, business, economic, competitive, political, and social uncertainties and contingencies. In making forward-looking statements, Perimeter may make various material assumptions, including but not limited to (i) the accuracy of Perimeter's financial projections; (ii) obtaining positive results from trials; (iii) obtaining necessary regulatory approvals; and (iv) general business, market and economic conditions. Further risks, uncertainties and assumptions include, but are not limited to, those applicable to Perimeter and described the joint information circular dated May 12, 2020, prepared in respect of the securityholder meetings held on June 17, 2020 a copy of which is available on Perimeter's SEDAR profile at www.sedar.com, and could cause actual events or results to differ materially from those projected in any forward-looking statements. In particular, we note the risk that our technology may not achieve the anticipated benefits in terms of surgical outcomes. Perimeter does not intend, nor does Perimeter undertake any obligation, to update or revise any forward-looking information contained in this news release to reflect subsequent information, events, or circumstances or otherwise, except if required by applicable laws.

SOURCE: Perimeter Medical Imaging



View source version on accesswire.com:
https://www.accesswire.com/608844/Perimeter-Medical-Imaging-AI-Announces-Further-Update-Regarding-Second-Quarter-Financial-Statements

News Provided by ACCESSWIRE via QuoteMedia

KWESST Micro Systems Taps AMW PR to Lead Public Relations, Media Strategy Initiatives

KWESST Micro Systems Taps AMW PR to Lead Public Relations, Media Strategy Initiatives

National U.S. Public Relations Firm Will Bring KWESST's Story and Proprietary Systems to Media, Public Markets

KWESST Micro Systems Inc. (OTCQB: KWEMF) (TSXV: KWE) ("KWESST," or "the Company"), a leader in providing next-generation tactical systems for security forces and personal defense, is pleased to announce that it has engaged the New York-based public relations firm AMW Public Relations to lead the Company's public relations, brand strategy, and media communications initiatives.

Keep reading... Show less
OTC Markets Group Welcomes ProStar Holdings Inc to OTCQX

OTC Markets Group Welcomes ProStar Holdings Inc to OTCQX

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for over 11,000 U.S. and global securities, today announced ProStar Holdings Inc (TSX-V: MAPS;  OTCQX: MAPPF), a leader in Precision Mapping Solutions, has qualified to trade on the OTCQX® Best Market. ProStar upgraded to OTCQX from the OTCQB® Venture Market.

ProStar begins trading today on OTCQX under the symbol "MAPPF."  U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com .

Keep reading... Show less
InvestmentPitch Media Video Discusses Cloud DX's Selection by Medtronic for Canada-Wide Remote Patient Monitoring - Video Available on Investmentpitch.com

InvestmentPitch Media Video Discusses Cloud DX's Selection by Medtronic for Canada-Wide Remote Patient Monitoring - Video Available on Investmentpitch.com

Cloud DX Inc. (TSXV: CDX) (OTCQB: CDXFF) has been selected by Medtronic Canada ULC, to provide world-class virtual healthcare to Medtronic's patients across Canada. Medtronic Canada, (www.medtronic.ca) headquartered in Brampton, Ontario, with regional offices in Montreal and Vancouver, is the largest medical technology company in Canada, and a subsidiary of Medtronic plc (NYSE: MDT), a multi billion-dollar, global leader in medical technology, offering medical devices and therapies to more than 72 million people across 150 countries.

For more information, please view the InvestmentPitch Media "video" which provides additional information about this news and the company, along with comments from Robert Kaul, CEO of Cloud DX, about the significance of this news. If this link is not enabled, please visit www.InvestmentPitch.com and enter "Cloud DX" in the search box.

Keep reading... Show less
The Power Play by The Market Herald Releases New Interviews with Cloud DX, Reklaim, Pacific Ridge and Legible

The Power Play by The Market Herald Releases New Interviews with Cloud DX, Reklaim, Pacific Ridge and Legible

The Power Play by The Market Herald has announced the release of new interviews with Cloud DX, Reklaim, Pacific Ridge and Legible discussing their latest press releases

The Power Play by The Market Herald provides investors with a quick snapshot of what they need to know about the company's latest press release through exclusive insights and interviews with company executives.

Keep reading... Show less

Nanalysis to Present at December Investor Conferences

Nanalysis Scientific Corp. ("Nanalysis", TSXV: NSCI OTCQX: NSCIF FRA: 1N1 ) will be presenting at three upcoming investor conferences in December. We encourage shareholders to listen in and book meetings in order to stay up to date with our developments.

Keep reading... Show less
Cloud DX selected by Medtronic for national collaboration

Cloud DX selected by Medtronic for national collaboration

Medtronic selected Cloud DX for virtual and remote patient monitoring (RPM) solutions in exclusive corporate agreement

Cloud DX (TSXV: CDX) (OTCQB: CDXFF) has been selected by Medtronic Canada ULC, a subsidiary of Medtronic plc (NYSE: MDT), a global leader in healthcare technology, to provide world-class virtual healthcare to patients across Canada . This partnership advances Medtronic's commitment to improving patient outcomes and lowering overall costs along the care continuum. Cloud DX's remote patient monitoring (RPM) technology and services are exclusive to Medtronic and its Canadian client base, which is spread across Canada. Medtronic Canada delivers care in a broad range of clinical areas, including spinal and cardiac surgeries, cardiology, critical care, diabetes, vascular and renal care. Most clinical areas are expected to improve patient outcomes and satisfaction with some aspect of virtual care in the future. Initially, Medtronic seeks to integrate the Connected Health TM platform and associated services within both perioperative and complex chronic disease pathways in Canada .

Keep reading... Show less

Top News

Related News